Hyperfine (HYPR) Capital Expenditures (2021 - 2026)
Hyperfine's (HYPR) quarterly Capital Expenditures came in at $69000.0 in Q1 2026, up 153.91% YoY from $27175.4 in Q1 2025, and up 9.52% on a QoQ basis from $63000.0 in Q4 2025.
Hyperfine (HYPR) Capital Expenditures (2021 - 2026) Analysis & Trends
Hyperfine (HYPR) has 6 years of Capital Expenditures data on file, last reported at $69000.0 in Q1 2026.
- Quarterly Capital Expenditures rose 153.91% year-over-year to $69000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.4 million (up 215.65% YoY) and the FY2025 annual result came in at $1.2 million, up 464.62% from the prior year.
- Capital Expenditures rose to $69000.0 in Q1 2026, from $63000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $1.1 million in Q2 2025 to a low of -$896000.0 in Q4 2024.
- A 5-year average of $104764.7 and a median of $62000.0 in 2022 frame the typical range for Capital Expenditures.
- Annual changes were most pronounced in 2024 — Capital Expenditures tumbled 347.51% — and 2025, when it jumped 16100.0%.
- Tracing HYPR's Capital Expenditures over 5 years: stood at $205000.0 in 2022, then jumped by 76.59% to $362000.0 in 2023, then plunged by 347.51% to -$896000.0 in 2024, then soared by 107.03% to $63000.0 in 2025, then climbed by 9.52% to $69000.0 in 2026.
- The last three Capital Expenditures figures came in at $69000.0 (Q1 2026), $63000.0 (Q4 2025), and $130000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | 497.00 Mn |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 202.00 Mn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 488.00 Mn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 195.00 Mn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 66.90 Mn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 84.70 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 100.00 Mn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | -74.39 Mn |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 87.50 Mn |
| 10 | Hyperfine | 88.36 Mn | 43.60 Mn | 1.98 Mn | 30,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 30,000.00 |
| Jun 30, 2026 | 30,000.00 |
| Mar 31, 2026 | 69,000.00 |
| Mar 31, 2026 | 69,000.00 |
| Dec 31, 2025 | 63,000.00 |
| Dec 31, 2025 | 63,000.00 |
| Sep 30, 2025 | 130,000.00 |
| Sep 30, 2025 | 130,000.00 |
| Jun 30, 2025 | 1.12 Mn |
| Jun 30, 2025 | 1.12 Mn |
| Mar 31, 2025 | -128,000.00 |
| Mar 31, 2025 | -128,000.00 |
| Dec 31, 2024 | -896,000.00 |
| Dec 31, 2024 | -896,000.00 |
| Sep 30, 2024 | -164,000.00 |
| Sep 30, 2024 | -164,000.00 |
| Jun 30, 2024 | -7,000.00 |
| Jun 30, 2024 | -7,000.00 |
| Mar 31, 2024 | 742,000.00 |
| Mar 31, 2024 | 742,000.00 |